Spots Global Cancer Trial Database for locally advanced resectable adenocarcinoma of the esophagogastric juction or the stomach
Every month we try and update this database with for locally advanced resectable adenocarcinoma of the esophagogastric juction or the stomach cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric Cancer | NCT01216644 | Gastric Cancer | 5-Fluorouracil Leucovorin Oxaliplatin Docetaxel Epirubicin Cisplatin 5-fluorouracil | 18 Years - | Krankenhaus Nordwest | |
5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric Cancer | NCT01216644 | Gastric Cancer | 5-Fluorouracil Leucovorin Oxaliplatin Docetaxel Epirubicin Cisplatin 5-fluorouracil | 18 Years - | Krankenhaus Nordwest |